Atlas Trials

A Phase 2 Study of Elobixibat in Adults With NAFLD or NASH

Clinical trial NCT04006145 · COMPLETED

Trial details

NCT number
NCT04006145
Sponsor
Albireo
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
NAFLDNASH
Start date
2019-06-06
Primary completion
2020-06-26
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.